1. Home
  2. ZS vs WST Comparison

ZS vs WST Comparison

Compare ZS & WST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Zscaler Inc.

ZS

Zscaler Inc.

HOLD

Current Price

$153.52

Market Cap

24.7B

Sector

Technology

ML Signal

HOLD

Logo West Pharmaceutical Services Inc.

WST

West Pharmaceutical Services Inc.

HOLD

Current Price

$240.59

Market Cap

17.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ZS
WST
Founded
2007
1923
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
24.7B
17.9B
IPO Year
2018
2004

Fundamental Metrics

Financial Performance
Metric
ZS
WST
Price
$153.52
$240.59
Analyst Decision
Buy
Buy
Analyst Count
38
7
Target Price
$268.57
$319.43
AVG Volume (30 Days)
3.1M
699.1K
Earning Date
01-01-0001
05-15-2026
Dividend Yield
N/A
0.37%
EPS Growth
30.77
1.49
EPS
N/A
6.79
Revenue
N/A
$2,886,900,000.00
Revenue This Year
$27.60
$6.73
Revenue Next Year
$19.67
$6.07
P/E Ratio
N/A
$34.72
Revenue Growth
N/A
1.95
52 Week Low
$140.56
$187.43
52 Week High
$336.99
$322.34

Technical Indicators

Market Signals
Indicator
ZS
WST
Relative Strength Index (RSI) 39.78 46.38
Support Level $140.56 $238.31
Resistance Level $166.10 $251.73
Average True Range (ATR) 7.14 6.47
MACD 1.61 -0.79
Stochastic Oscillator 47.00 39.68

Price Performance

Historical Comparison
ZS
WST

About ZS Zscaler Inc.

Zscaler is a software-as-a-service, or SaaS, firm focusing on providing cloud-native cybersecurity solutions to primarily enterprise customers. Zscaler's offerings can be broadly partitioned into Zscaler Internet Access, which provides secure access to external applications, and Zscaler Private Access, which provides secure access to internal applications. The firm is headquartered in San Jose, California, and went public in 2018.

About WST West Pharmaceutical Services Inc.

West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.

Share on Social Networks: